DigestRedComo funciona
Red
/
Empresas
Ch
No verificado

Chiesi Group

Sobre qué escribimos

BiotecnologíaCienciaFarmacéuticaSaludSanidad

14 Comunicados de prensa

Ver todos los comunicados de prensa
15/09/2026
Biotecnología
Salud
Ciencia
Farmacéutica
Mercado laboral
Chiesi nomina David Khougazian Chief Executive Officer del Gruppo per guidare la prossima fase di crescita sostenuta dall’innovazione
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
15/09/2026
Biotecnología
Salud
Ciencia
Farmacéutica
Mercado laboral
Chiesi Appoints David Khougazian as Group Chief Executive Officer to Lead the Next Phase of Innovation-Driven Growth
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
09/09/2026
Mercado de valores
Biotecnología
Salud
Ciencia
Farmacéutica
Gruppo Chiesi: solida performance nel primo semestre 2026, tra crescita, continui investimenti nell’innovazione e un impatto economico positivo sulle comunità
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
09/09/2026
Mercado de valores
Biotecnología
Salud
Ciencia
Farmacéutica
Chiesi Group Delivers Solid H1 2026 Performance, Combining Growth, Continued Investment in Innovation and Positive Economic Impact Across Communities
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
03/09/2026
Industria
Biotecnología
Farmacéutica
Medio Ambiente/Ecología
Sanidad
Salud
Chiesi Advances Its Carbon Minimal Inhaler Journey as European Submissions for Its Single Inhaler Triple Therapy (SITT) and ICS/LABA Combination Next-Generation Propellant pMDIs Are Validated
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
25/06/2026
Biotecnología
Medicina Salud Bienestar
Anuncios breves
Chiesi Group and Arbor Biotechnologies Announce ABO-101 Granted Orphan Drug Designation by European Commission for Primary Hyperoxaluria
Fuente
Chiesi Group
Editor
GLOBENEWSWIRE
1.00
0
20/05/2026
Chiesi Group Announces New Chair and Vice Chair
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
20/05/2026
Chiesi Annuncia La Nuova Presidente E Il Nuovo Vicepresidente
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
11/03/2026
Chiesi e Bespak collaborano per avanzare nella produzione di inalatori a emissioni ridotte di carbonio in un sito produttivo nel Regno Unito
Fuente
Chiesi Group
Editor
Business Wire
1.00
0
11/03/2026
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site
Fuente
Chiesi Group
Editor
Business Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0